BioSpace News Archive

Drug Development

Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Polycythemia Vera

Protagonist Therapeutics, Inc. announced that the first patient has been dosed in a Phase 2 study of PTG-300 in patients with polycythemia vera, a myeloproliferative disorder characterized by overproduction of red blood cells..

October 30, 2019
·
5 min read
Business

Vantage EyeCare, LLC Announces Continued Growth into 2020

Vantage EyeCare, LLC is pleased to announce the addition of Dr. Allen Richmond to its Northern Ophthalmic Associates Division, and welcomes Valley Eye Professionals as its newest Division..

October 30, 2019
·
4 min read
Business

Nektar to Announce Financial Results for the Third Quarter 2019 on Wednesday, November 6, 2019, After Close of U.S.-Based Financial Markets

Nektar Therapeutics will announce its financial results for the third quarter on Wednesday, November 6, 2019, after the close of U.S.-based financial markets.

October 30, 2019
·
1 min read
Policy

Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada

Knight Therapeutics Inc. and TherapeuticsMD, Inc. announced today that Knight’s New Drug Submission for Joyesta™ has been accepted for review by Health Canada.

October 30, 2019
·
6 min read
BioMidwest

CRB named Company of the Year by the International Society for Pharmaceutical Engineering

CRB was recognized as the 2019 Company of the Year by the International Society for Pharmaceutical Engineering during the organization’s annual meeting in Las Vegas, Nevada on Oct. 27–30, 2019..

October 30, 2019
·
1 min read
Biotech Beach

Huntington Hospital named America’s 100 Best for Cardiac Care and 100 Best for Coronary Intervention

New report identifies Huntington Hospital among the top hospitals nationally for excellence in Cardiac Care

October 30, 2019
·
3 min read
Policy

Outcome Health Reaches Favorable Resolution with the DOJ Related to Past Misconduct by Former Employees

Company has established and continues to make significant investments in industry-leading compliance protocols and reporting standards

October 30, 2019
·
2 min read
Biotech Beach

The Discovery Of Amgen’s Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature

Publication Showcases how First-to-Clinic Investigational AMG 510 Exploits a Cryptic Groove of the Previously Undruggable KRAS Protein Surface

October 30, 2019
·
11 min read
Policy

Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15)

Agile Therapeutics, Inc., a women’s healthcare company, announced a positive outcome from today’s meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee of the U.S. Food and Drug Administration

October 30, 2019
·
5 min read
Business

Historic lab at CSHL transformed for future cancer research

After two years of extensive renovation and with generous support from New York State, Cold Spring Harbor Laboratory’s historic Demerec laboratory is reborn as a state-of-the-art research facility.

October 30, 2019
·
2 min read